Article
The chemotherapeutic CX-5461 primarily targets TOP2B and exhibits selective activity in…
bioRxiv · 2021 · Min Pan
Key facts
| Title | The chemotherapeutic CX-5461 primarily targets TOP2B and exhibits selective activity in high-risk neuroblastoma |
|---|---|
| First author | Min Pan |
| Journal | bioRxiv |
| Published | Feb 25, 2021 |
| DOI | 10.1101/2021.02.25.432934 |
| Devices mentioned | K042152, K073490, K133972, K142003, K170858, K191495, K192440, K192932, K212956, K823719, K940422, K982100 |
| Product codes mentioned | CFN, DFZ, HKI, IZH, IZL, MQB, MUE, OWB, JAA |
At a glance
- 10–99 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1